most citedEnd-To-End Clinical Trial Matching with Large Language Models

13 citations · 32 across the 6 of their papers we have counts for

collaborators

6 papers

cs.CL2025★ 3 cited

LLM Agents Making Agent Tools

Georg Wölflein, Dyke Ferber, Daniel Truhn +2

Tool use has turned large language models (LLMs) into powerful agents that can perform complex multi-step tasks by dynamically utilising external software components. However, thes…

cs.CV2024

Abnormality-Driven Representation Learning for Radiology Imaging

Marta Ligero, Tim Lenz, Georg Wölflein +3

To date, the most common approach for radiology deep learning pipelines is the use of end-to-end 3D networks based on models pre-trained on other tasks, followed by fine-tuning on…

cs.CV2024★ 2 cited

Unsupervised Foundation Model-Agnostic Slide-Level Representation Learning

Tim Lenz, Peter Neidlinger, Marta Ligero +3

Representation learning of pathology whole-slide images (WSIs) has primarily relied on weak supervision with Multiple Instance Learning (MIL). This approach leads to slide represen…

cs.CL2024★ 13 cited

End-To-End Clinical Trial Matching with Large Language Models

Dyke Ferber, Lars Hilgers, Isabella C. Wiest +13

Matching cancer patients to clinical trials is essential for advancing treatment and patient care. However, the inconsistent format of medical free text documents and complex trial…

cs.AI2024★ 12 cited

Autonomous Artificial Intelligence Agents for Clinical Decision Making in Oncology

Dyke Ferber, Omar S. M. El Nahhas, Georg Wölflein +11

Multimodal artificial intelligence (AI) systems have the potential to enhance clinical decision-making by interpreting various types of medical data. However, the effectiveness of…

eess.IV2024★ 2 cited

Joint multi-task learning improves weakly-supervised biomarker prediction in computational pathology

Omar S. M. El Nahhas, Georg Wölflein, Marta Ligero +5

Deep Learning (DL) can predict biomarkers directly from digitized cancer histology in a weakly-supervised setting. Recently, the prediction of continuous biomarkers through regress…